Stefano Ceruti
Anna University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stefano Ceruti.
Journal of Neuroimmunology | 2002
Enrico Fainardi; Enrico Granieri; Maria Rosaria Tola; Loredana Melchiorri; Luca Vaghi; Roberta Rizzo; Massimiliano Castellazzi; Stefano Ceruti; Ezio Paolino; Olavio R. Baricordi
The goal of our study was to clarify the contribution of soluble human leukocyte antigens class I (sHLA-I) in multiple sclerosis (MS) immune dysregulation. We retrospectively evaluated by ELISA cerebrospinal fluid (CSF) and serum sHLA-I levels in 79 relapsing-remitting (RR), 26 secondary progressive (SP) and 15 primary progressive (PP) MS patients stratified according to clinical and Magnetic Resonance Imaging (MRI) evidence of disease activity. One hundred and nine patients with other inflammatory neurological disorders (OIND), 88 with noninflammatory neurological disorders (NIND) and 82 healthy donors were used as controls. An intrathecal synthesis of sHLA-I detected by a specific index was significantly more consistent in MS than in controls, with more pronounced values in MS patients with relapses and MRI enhancing brain lesions. A decrease in serum sHLA-I concentrations was observed in MS patients with demyelinating attacks, while an increase in CSF levels of sHLA-I was found in MS patients with lesional activity on MRI scans. This association between intrathecal synthesis and reciprocal fluctuations of CSF and serum levels of sHLA-I in clinically and MRI active MS seems to suggest a potential role for CSF and serum levels of sHLA-I as a sensitive marker of immune activation taking place both intrathecally and systemically in MS.
American Journal of Medical Genetics Part A | 2011
Alberto Sensi; Stefano Ceruti; Patrizia Trevisi; Francesca Gualandi; Micol Busi; Ilaria Donati; Marcella Neri; Alessandra Ferlini; Alessandro Martini
We report on the first cases of FGF3 compound heterozygotes in two European families from non‐consanguineous marriages, affected with labyrinthine aplasia, microtia, and microdontia (LAMM) Syndrome. Three not previously described mutations (p.W153VfsX51, p.Y106C, and p.Y49C) and a recurrent one (p.R104X) were found. Analysis of 50 unrelated control subjects (100 chromosomes) of the same European background did not show any of the two newly reported missense variations. We confirm the absence of otodental syndrome in heterozygous carriers, but report unilateral microtia in one of them. We also report on the involvement of the middle ear structures in LAMM Syndrome.
PLOS ONE | 2016
Marina Padroni; Andrea Bernardoni; Carmine Tamborino; Gloria Roversi; Massimo Borrelli; Andrea Saletti; Alessandro De Vito; Cristiano Azzini; Luca Borgatti; Onofrio Marcello; Christopher D. d’Esterre; Stefano Ceruti; Ilaria Casetta; Ting-Yim Lee; Enrico Fainardi
Introduction The capability of CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS) to predict outcome and identify ischemia severity in acute ischemic stroke (AIS) patients is still questioned. Methods 62 patients with AIS were imaged within 8 hours of symptom onset by non-contrast CT, CT angiography and CTP scans at admission and 24 hours. CTP ASPECTS was calculated on the affected hemisphere using cerebral blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT) maps by subtracting 1 point for any abnormalities visually detected or measured within multiple cortical circular regions of interest according to previously established thresholds. MTT-CBV ASPECTS was considered as CTP ASPECTS mismatch. Hemorrhagic transformation (HT), recanalization status and reperfusion grade at 24 hours, final infarct volume at 7 days and modified Rankin scale (mRS) at 3 months after onset were recorded. Results Semi-quantitative and quantitative CTP ASPECTS were highly correlated (p<0.00001). CBF, CBV and MTT ASPECTS were higher in patients with no HT and mRS≤2 and inversely associated with final infarct volume and mRS (p values: from p<0.05 to p<0.00001). CTP ASPECTS mismatch was slightly associated with radiological and clinical outcomes (p values: from p<0.05 to p<0.02) only if evaluated quantitatively. A CBV ASPECTS of 9 was the optimal semi-quantitative value for predicting outcome. Conclusions Our findings suggest that visual inspection of CTP ASPECTS recognizes infarct and ischemic absolute values. Semi-quantitative CBV ASPECTS, but not CTP ASPECTS mismatch, represents a strong prognostic indicator, implying that core extent is the main determinant of outcome, irrespective of penumbra size.
Acta neurochirurgica | 2006
Enrico Fainardi; Massimo Borrelli; Andrea Saletti; Roberta Schivalocchi; M. Russo; Cristiano Sebastiano Azzini; Michele Alessandro Cavallo; Stefano Ceruti; Riccardo Tamarozzi; Arturo Chieregato
In this study, we investigated 40 patients (18 male, 22 female; mean age = 64.5 +/- 11.0; GCS = 9 to 14) with acute supratentorial spontaneous intracerebral hemorrhage (SICH) at admission by using a 1-tesla magnetic resonance imaging (MRI) unit equipped for single-shot echo-planar spin-echo isotropic diffusion-weighted imaging (DWI) sequences. All DWI studies were obtained within 48 hours after symptom onset. Regional apparent diffusion coefficient (rADC) values were measured in 3 different regions of interest (ROIs) drawn freehand on the T2-weighted images at b 0 s/mm2 on every section in which hematoma was visible: 1) the perihematomal hyperintense area; 2) 1 cm of normal appearing brain tissue surrounding the perilesional hyperintense rim; 3) an area mirroring the region including the clot and perihematomal hyperintense area placed in the contralateral hemisphere. rADC mean values were higher in perihematomal hyperintense and in contralateral than in normal appearing areas (p < 0.001), with increased rADC mean levels in all regions examined. Our findings show that rADC values indicative of vasogenic edema were present in the perihematomal area and in normal appearing brain tissue located both ipsilateral and contralateral to the hematoma, with lower levels in non-injured areas located in the T2 hyperintense rim around the clot.
Neuroradiology | 2008
Enrico Fainardi; Massimo Borrelli; Andrea Saletti; Roberta Schivalocchi; Cristiano Azzini; Michele Alessandro Cavallo; Stefano Ceruti; Riccardo Tamarozzi; Arturo Chieregato
Neuroradiology | 2014
Silvio Sarubbo; Francesco Latini; Stefano Ceruti; Arturo Chieregato; Christopher d'Esterre; Ting-Yim Lee; Michele Alessandro Cavallo; Enrico Fainardi
Neuroradiology | 2013
Enrico Fainardi; Massimo Borrelli; Andrea Saletti; Silvio Sarubbo; Gloria Roversi; Andrea Bernardoni; Francesco Latini; Cristiano Azzini; Luca Borgatti; Alessandro De Vito; Michele Alessandro Cavallo; Stefano Ceruti; Arturo Chieregato
BMC Neurology | 2015
Jun Yang; Christopher D. d’Esterre; Stefano Ceruti; Gloria Roversi; Andrea Saletti; Enrico Fainardi; Ting-Yim Lee
Neurological Sciences | 2015
Christopher D. d’Esterre; Gloria Roversi; Marina Padroni; Andrea Bernardoni; Carmine Tamborino; Alessandro De Vito; Cristiano Azzini; Onofrio Marcello; Andrea Saletti; Stefano Ceruti; Ting-Yim Lee; Enrico Fainardi
Journal of Medical Cases | 2013
Carla Ceriotti; Enrico Fainardi; Stefano Ceruti; Giovanni Zuliani